CaCO3 powder-mediated biomineralization of antigen nanosponges synergize with PD-1 blockade to potentiate anti-tumor immunity

J Nanobiotechnology. 2023 Apr 7;21(1):120. doi: 10.1186/s12951-023-01870-x.

Abstract

Antigen self-assembly nanovaccines advance the minimalist design of therapeutic cancer vaccines, but the issue of inefficient cross-presentation has not yet been fully addressed. Herein, we report a unique approach by combining the concepts of "antigen multi-copy display" and "calcium carbonate (CaCO3) biomineralization" to increase cross-presentation. Based on this strategy, we successfully construct sub-100 nm biomineralized antigen nanosponges (BANSs) with high CaCO3 loading (38.13 wt%) and antigen density (61.87%). BANSs can be effectively uptaken by immature antigen-presenting cells (APCs) in the lymph node upon subcutaneous injection. Achieving efficient spatiotemporal coordination of antigen cross-presentation and immune effects, BANSs induce the production of CD4+ T helper cells and cytotoxic T lymphocytes, resulting in effective tumor growth inhibition. BANSs combined with anti-PD-1 antibodies synergistically enhance anti-tumor immunity and reverse the tumor immunosuppressive microenvironment. Overall, this CaCO3 powder-mediated biomineralization of antigen nanosponges offer a robust and safe strategy for cancer immunotherapy.

Keywords: Antigen-presenting cells; Antigen-specific CD8+ T cell responses; Biomineralization; CaCO3 powder; Nanovaccine.

MeSH terms

  • Antigen-Presenting Cells
  • Biomineralization
  • CD8-Positive T-Lymphocytes
  • Cancer Vaccines* / therapeutic use
  • Humans
  • Immunotherapy / methods
  • Neoplasms* / drug therapy
  • Powders
  • Tumor Microenvironment

Substances

  • Powders
  • Cancer Vaccines